heparin lock flush solution injection usp
hospira healthcare ulc - heparin sodium - solution - 100unit - heparin sodium 100unit - heparins
heparin leo inj 1000unit/ml liquid
leo pharma inc - heparin sodium - liquid - 1000unit - heparin sodium 1000unit - heparins
heparin sodium and dextrose 5% inj usp liquid
baxter corporation - heparin sodium; dextrose - liquid - 4000unit; 5g - heparin sodium 4000unit; dextrose 5g - heparins
heparin sodium & dextrose 5% in viaflex liq solution
baxter corporation - heparin sodium; dextrose - solution - 5000unit; 5g - heparin sodium 5000unit; dextrose 5g - heparins
heparin sodium & 5% dextrose injection liq solution
baxter corporation - heparin sodium; dextrose - solution - 10000unit; 5g - heparin sodium 10000unit; dextrose 5g - heparins
heparin sodium 5000unit/500ml in sodium chloride 0.9% solution
hospira healthcare ulc - heparin sodium - solution - 10unit - heparin sodium 10unit - heparins
heparin sodium injection usp (multidose vial-with preservative) solution
sandoz canada incorporated - heparin sodium - solution - 1000unit - heparin sodium 1000unit - heparins
heparin sodium injection usp (single use vial-preservative free) solution
sandoz canada incorporated - heparin sodium - solution - 10000unit - heparin sodium 10000unit - heparins
heparin sodium injection usp (multidose vial-with preservative) solution
sandoz canada incorporated - heparin sodium - solution - 10000unit - heparin sodium 10000unit - heparins
heparin sodium - heparin sodium injection, solution, concentrate
general injectables & vaccines, inc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium 10000 [usp'u] in 5 ml - heparin sodium is indicated for: atrial fibrillation with embolization: diagnosis and treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and heart surgery; anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; (in a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease (see dosage and administration); prophylaxis and treatment of pulmonary embolism; prophylaxis and treatment of peripheral arterial embolism. heparin sodium should not be used in patients: with severe thrombocytopenia; in whom suitable blood coagulation tests — e.g., the whole blood clotting time, partial thromboplastin time, etc. — cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no ne